Insulin glargine, lixisenatide combination safe, effective for older adults with type 2 diabetes

A single injection combination of basal insulin glargine and lixisenatide known as iGlarLixi improves glycemic control without increasing the risk for severe hypoglycemia in older adults with type 2 diabetes, according to findings published in the Journal of Diabetes and its Complications. “We have a limited number of safe treatments for people above [age] 65 [years].

Source: Insulin glargine, lixisenatide combination safe, effective for older adults with type 2 diabetes